c-TACE | Conventional TACE (using Lipiodol®) |
DEB-TACE | Drug-eluting bead TACE |
RECIST | Response evaluation criteria in solid tumors |
NET | Neuroendocrine tumor |
OS | Overall survival |
mRECIST | Modified response evaluation criteria in solid tumors |
SSAs | Somatostatin analogs |
TACE | Transarterial chemoembolization |
TTLP | Time to liver progression |
TTUP | Time to untreatable progression |
WHO | World Health Organization |